Walnut Creek, CA, United States of America

Craig C Hodges

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Alexza Pharmaceuticals, Inc., Alexza Molecular Delivery Corporation, Varian Associates, Inc.. Active years: 1997-2021.

USPTO Granted Patents = 17 

% Patents Active = 17.6



Average Co-Inventor Count = 6.2

ph-index = 14

Forward Citations = 801(Granted Patents)


Company Filing History:


Years Active: 1997-2021

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Craig C. Hodges: Innovator in Inhalation Therapy

Introduction

Craig C. Hodges is a notable inventor based in Walnut Creek, California, with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in inhalation therapy, contributing significantly to the medical field.

Latest Patents

Among his latest innovations, Hodges has developed an aerosol forming device for use in inhalation therapy. This device is designed to deliver drug-containing aerosols effectively, utilizing a housing and an airway that incorporates a gas/vapor mixing airway. The device features a subassembly with a metallic substrate coated with a drug composition, facilitating the formation of drug-containing aerosols for therapeutic use. Additionally, he has created novel condensation aerosols aimed at treating various diseases and conditions. These aerosols are characterized by minimal pyrolysis degradation products and an MMAD of between 1-3 microns. The process involves rapidly heating a drug-coated substrate while passing gas over it, resulting in particles suitable for inhalation. His patents also include kits that combine a drug with a device for producing condensation aerosols, ensuring a therapeutically effective dose when administered.

Career Highlights

Hodges has had a distinguished career, working with prominent companies such as Alexza Pharmaceuticals, Inc. and Alexza Molecular Delivery Corporation. His contributions to these organizations have been pivotal in advancing inhalation therapy technologies.

Collaborations

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…